Pediatrix Medical Group, Inc. (MD) FY2026 Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
Pediatrix Medical Group, Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $39,843,000.00Accounts payable and accrued expenses → Operating adjustments reconciliation: $63,942,000.00Deferred income taxes → Operating adjustments reconciliation: $11,446,000.00Depreciation and amortization → Operating adjustments reconciliation: $5,782,000.00Stock-based compensation expense → Operating adjustments reconciliation: $5,075,000.00Prepaid expenses and other current assets → Operating adjustments reconciliation: $3,926,000.00Other long-term assets → Operating adjustments reconciliation: $2,503,000.00Income taxes payable → Operating adjustments reconciliation: $702,000.00Amortization of premiums, discounts and issuance costs → Operating adjustments reconciliation: $49,000.00Operating adjustments reconciliation → Net cash from operating activities: $85,480,000.00Operating adjustments reconciliation → Other liabilities: $3,192,000.00Operating adjustments reconciliation → Accounts receivable: $2,800,000.00Operating adjustments reconciliation → Net cash used in operating activities - discontinued operations: $986,000.00Operating adjustments reconciliation → Other: $662,000.00Operating adjustments reconciliation → Long-term professional liabilities: $305,000.00Proceeds from maturities or sales of investments → investing reconciliation: $10,450,000.00investing reconciliation → Net cash from investing activities: $6,019,000.00investing reconciliation → Purchases of investments: $3,052,000.00investing reconciliation → Purchases of property and equipment: $1,379,000.00Net cash used in financing activities → financing reconciliation: $48,243,000.00Proceeds from issuance of common stock → financing reconciliation: $1,070,000.00financing reconciliation → Repurchases of common stock: $42,744,000.00financing reconciliation → Payments on term loan: $6,250,000.00financing reconciliation → Payments on finance lease obligations: $319,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $205,780,000.00Net cash from operating activities → Cash sources and uses: $125,323,000.00Net cash from investing activities → Cash sources and uses: $6,019,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $288,879,000.00Cash sources and uses → Net cash used in financing activities: $48,243,000.00Net cash used in operating activities - discontinued operations: -$986,000.00Discontinued operations cash−$986.00 KNet income: $39,843,000.00Net income+$39.84 MDepreciation and amortization: $5,782,000.00Depreciation & amortization+$5.78 MAmortization of premiums, discounts and issuance costs: $49,000.00Debt cost amortization+$49.00 KStock-based compensation expense: $5,075,000.00Stock-based compensation+$5.08 MDeferred income taxes: $11,446,000.00Deferred income taxes+$11.45 MOther: -$662,000.00Other non-cash items−$662.00 KAccounts receivable: -$2,800,000.00Accounts receivable−$2.80 MPrepaid expenses and other current assets: $3,926,000.00Prepaid & other assets+$3.93 MOther long-term assets: $2,503,000.00Other noncurrent assets+$2.50 MAccounts payable and accrued expenses: $63,942,000.00Payables & accrued liabilities+$63.94 MIncome taxes payable: $702,000.00Income taxes payable+$702.00 KLong-term professional liabilities: -$305,000.00Claims reserves−$305.00 KOther liabilities: -$3,192,000.00Other operating liabilities−$3.19 MNet cash from operating activities: $125,323,000.00Operating cash+$125.32 MOperating adjustments reconciliation: $93,425,000.00Payments on term loan: -$6,250,000.00Payments on term loan−$6.25 MPayments on finance lease obligations: -$319,000.00Finance lease payments−$319.00 KProceeds from issuance of common stock: $1,070,000.00Common stock issued+$1.07 MRepurchases of common stock: -$42,744,000.00Common stock repurchases−$42.74 MOther: $0.00Net cash used in financing activities: -$48,243,000.00. Cash required to fund net payments.Financing cash−$48.24 Mfinancing reconciliation: $49,313,000.00Acquisition payments, net of cash acquired: $0.00Purchases of investments: -$3,052,000.00Investment purchases−$3.05 MProceeds from maturities or sales of investments: $10,450,000.00Other investment proceeds+$10.45 MPurchases of property and equipment: -$1,379,000.00Other PP&E purchases−$1.38 MOther: $0.00Net cash from investing activities: $6,019,000.00Investing cash+$6.02 Minvesting reconciliation: $10,450,000.00Cash sources and uses: $337,122,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $205,780,000.00Beginning cash$205.78 MEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $288,879,000.00Ending cash$288.88 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flowNot availableCash flow / Net income3.15×Operating cash flow ÷ net incomeNet cash change+$83.10 MEnding cash − beginning cash
Chart details

Pediatrix Medical Group, Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
205,780,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
125,323,000 US dollars. Net cash provided.
Net income
39,843,000 US dollars
Net cash used in operating activities - discontinued operations
negative 986,000 US dollars
Depreciation and amortization
5,782,000 US dollars
Amortization of premiums, discounts and issuance costs
49,000 US dollars
Stock-based compensation expense
5,075,000 US dollars
Deferred income taxes
11,446,000 US dollars
Other
negative 662,000 US dollars
Accounts receivable
negative 2,800,000 US dollars
Prepaid expenses and other current assets
3,926,000 US dollars
Other long-term assets
2,503,000 US dollars
Accounts payable and accrued expenses
63,942,000 US dollars
Income taxes payable
702,000 US dollars
Long-term professional liabilities
negative 305,000 US dollars
Other liabilities
negative 3,192,000 US dollars
Investing activities
6,019,000 US dollars. Net cash provided.
Acquisition payments, net of cash acquired
0 US dollars
Purchases of investments
negative 3,052,000 US dollars
Proceeds from maturities or sales of investments
10,450,000 US dollars
Purchases of property and equipment
negative 1,379,000 US dollars
Other
0 US dollars
Financing activities
negative 48,243,000 US dollars. Net cash used.
Payments on term loan
negative 6,250,000 US dollars
Payments on finance lease obligations
negative 319,000 US dollars
Proceeds from issuance of common stock
1,070,000 US dollars
Repurchases of common stock
negative 42,744,000 US dollars
Other
0 US dollars
Operating adjustment reconciliation
93,425,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
49,313,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
10,450,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
288,879,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
337,122,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
83,099,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
3.15×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $85.48M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
Pediatrix Medical Group, Inc. (MD) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!